Security key
92829J203
Dogwood Therapeutics, Inc. - Common Stock, par value $0.0001 (DWTX)
CUSIP: 92829J203
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, par value $0.0001
- Total 13F shares
- 3,619,770
- Total 13F value
- $7,637,717
- Share change
- +3,384,645
- SEC-reported price per share
- $2.11
- Number of holders
- 13
- Value change
- +$7,121,325
- Number of buys
- 7
- Number of sells
- 2
- Shares outstanding
- 33,464,665
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
13
Top holders
10
DWTX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Dogwood Therapeutics, Inc. SEC filings
Dogwood Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92829J203
Recent filing periods:
Ownership snapshot
Top reported holders of DWTX - Dogwood Therapeutics, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sealbond Ltd
Disclosed value leader
Sealbond Ltd
Comparable rows
13/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 83%
2 rows are not safely comparable across share classes.
13D/G row: Sealbond Ltd
Showing 1-6 of 15 holder rows.
Quick read
Sealbond Ltd leads the comparable SEC ownership view at 83%.
13 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sealbond Ltd's linked filing trail.
Comparable ownership
Top 5
Sealbond Ltd
83%
ARMISTICE CAPITAL, LLC
10%
Orca Capital AG
3.7%
VANGUARD GROUP INC
0.09%
GEODE CAPITAL MANAGEMENT, LLC
0.05%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sealbond Ltd |
13D/G
3/4/5
CK Life Sciences Int'l., (Holdings) Inc. · Director, Other*, 10%+ Owner
|
83%
|
$164,022,057
24,664,971 shares
|
+$162,616,360 | 21 Nov 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
10%
|
$7,053,983
3,343,120 shares
|
$0 | 31 Mar 2026 |
| Orca Capital AG |
13D/G
|
3.7%
|
$390,299
69,821 shares
|
-$256,967 | 14 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.09%
|
$124,613
29,955 shares
|
— | 31 Dec 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.05%
|
$69,805
16,779 shares
|
— | 31 Dec 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
0.03%
|
$48,485
11,655 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
3,619,770
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
10
Q1 2026 holders
13
Holder diff
3
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend